Small Molecules
10 June 2014
MEI Pharma Reports High Response Rates In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia9 June 2014
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease9 June 2014
Valeant Pharmaceuticals Announces FDA Approval Of Jublia® for the Treatment of Onychomycosis5 June 2014
Revive Therapeutics Ltd. Submits Pre-IND Package to the US FDA for Its Gout Drug Candidate, REV-002News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports